跳至主要内容
临床试验/NCT02506894
NCT02506894已完成早期 1 期

Fetal Middle Cerebral Artery Doppler in Preterm Births Receiving Magnesium Sulfate for Neuroprotection

Cairo University1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2015年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
已完成
入组人数
60
试验地点
1
主要终点
changes in fetal middle cerebral artery Doppler indices

研究概览

简要总结

Two groups of women with preterm labor will be included. One will receive magnesium sulfate for neuroprotection and the other will receive placebo. Fetal middle cerebral artery Doppler indices will be measured before and after intake of either magnesium sulfate or placebo to find if any significant changes occur in fetal cerebral blood flow.

详细描述

The study will include women with preterm labor with gestational age less than 32 weeks. women will be randomized to receive either magnesium sulfate (loading dose 6 g over 20 minutes followed by maintenance dose of 1 g/hour for 24 hours), or placebo in the form of sodium chloride solution 0.9% over 24 hours. Fetal middle cerebral artery Doppler indices [Peak systolic velocity (PSV), Pulsatility index (PI), and resistance index (RI)] will be recorded before and after treatment in both groups. Results of Doppler indices will be compared between both groups and before and after intake of magnesium sulfate to find out if middle cerebral artery Doppler of the fetus can explain the mechanism behind the use of magnesium sulfate for fetal neuroprotection in preterm births.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
Double (Participant, Investigator)

入排标准

年龄范围
20 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • pregnant women with preterm labor
  • gestational age less than 32 weeks
  • singleton pregnancy

排除标准

  • contraindication or hypersensitivity to magnesium
  • preeclampsia
  • multiple pregnancy
  • intake of magnesium sulfate in this pregnancy before

研究组 & 干预措施

magnesium sulfate

Active Comparator

this group will receive magnesium sulfate loading dose 6 g in 500 cc of ringer solution over 20 minutes then maintenance dose of 1 g/ hour for 24 hours.

干预措施: Magnesium Sulfate (Drug)

placebo group

Placebo Comparator

this group will receive sodium chloride 0.9% solution for 24 hours.

干预措施: 0.9% sodium chloride solution (Other)

结局指标

主要结局

changes in fetal middle cerebral artery Doppler indices

时间窗: 3 months

次要结局

  • maternal adverse effects of magnesium sulfate(3 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ghada Abdel Fattah

assistant professor of Obstetrics and Gynecology

Cairo University

研究点 (1)

Loading locations...

相似试验